Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ravi Viswanathan currently holds 5,733 shares of Epizyme, Inc. (EPZM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ravi Viswanathan has been a net buyer of EPZM stock. They have purchased $268.2M and sold $134.6M worth of shares.
Ravi Viswanathan's most recent insider trade was on Jun 24, 2022, when they sold 5,733 shares at $0.00 per share.
Ravi Viswanathan serves as Executive at Epizyme, Inc. (EPZM). They have executed 191 insider transactions totaling $402.8M over their tenure at the company.
Ravi Viswanathan holds the position of Executive at Epizyme, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Ravi Viswanathan has shown a buying trading pattern, with $268.2M in total purchases and $134.6M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ravi Viswanathan was on Sep 7, 2018, when they purchased $20.0M worth of ADAP shares. This transaction involved 12,000,000 shares at $1.67 per share.
Ravi Viswanathan currently owns 5,733 shares of Epizyme, Inc. (EPZM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ravi Viswanathan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ravi Viswanathan has 191 Form 4 filings on record as an insider at Epizyme, Inc..
Set alerts for Ravi Viswanathan and 40,000+ other insiders.